Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 327

1.

Generalization after ocular onset in myasthenia gravis: a case series in Germany.

Li F, Hotter B, Swierzy M, Ismail M, Meisel A, Rückert JC.

J Neurol. 2018 Sep 17. doi: 10.1007/s00415-018-9056-8. [Epub ahead of print]

PMID:
30225725
2.

Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MS.

Scheibe F, Metz I, Radbruch H, Siebert E, Wolf S, Köhnlein M, Harms L, Meisel A.

Neurol Neuroimmunol Neuroinflamm. 2018 Jul 10;5(5):e479. doi: 10.1212/NXI.0000000000000479. eCollection 2018 Sep. No abstract available.

3.

Microbiological Etiologies of Pneumonia Complicating Stroke: A Systematic Review.

Kishore AK, Vail A, Jeans AR, Chamorro A, Di Napoli M, Kalra L, Langhorne P, Roffe C, Westendorp W, Nederkoorn PJ, Garau J, van de Beek D, Montaner J, Woodhead M, Meisel A, Smith CJ; Pneumonia in Stroke Consensus (PISCES) Group.

Stroke. 2018 Jul;49(7):1602-1609. doi: 10.1161/STROKEAHA.117.020250. Epub 2018 Jun 18.

PMID:
29915122
4.

Intravenous versus subcutaneous immunoglobulin - Authors' reply.

van Schaik IN, Mielke O; PATH study group.

Lancet Neurol. 2018 May;17(5):393-394. doi: 10.1016/S1474-4422(18)30109-1. No abstract available.

PMID:
29656738
5.

Neurofascin and Compact Myelin Antigen-Specific T Cell Response Pattern in Chronic Inflammatory Demyelinating Polyneuropathy Subtypes.

Diederich JM, Staudt M, Meisel C, Hahn K, Meinl E, Meisel A, Klehmet J.

Front Neurol. 2018 Mar 19;9:171. doi: 10.3389/fneur.2018.00171. eCollection 2018.

6.

Immunomodulatory treatment with systemic GM-CSF augments pulmonary immune responses and improves neurological outcome after experimental stroke.

Dames C, Winek K, Beckers Y, Engel O, Meisel A, Meisel C.

J Neuroimmunol. 2018 Aug 15;321:144-149. doi: 10.1016/j.jneuroim.2018.03.005. Epub 2018 Mar 9.

7.

Association between the time after transplantation and different immunosuppressive medications with dental and periodontal treatment need in patients after solid organ transplantation.

Schmalz G, Wendorff H, Berisha L, Meisel A, Widmer F, Marcinkowski A, Teschler H, Sommerwerck U, Haak R, Kollmar O, Ziebolz D.

Transpl Infect Dis. 2018 Apr;20(2):e12832. doi: 10.1111/tid.12832. Epub 2018 Feb 21.

PMID:
29359871
8.

Analysis of anti-ganglioside antibodies by a line immunoassay in patients with chronic-inflammatory demyelinating polyneuropathies (CIDP).

Klehmet J, Märschenz S, Ruprecht K, Wunderlich B, Büttner T, Hiemann R, Roggenbuck D, Meisel A.

Clin Chem Lab Med. 2018 May 24;56(6):919-926. doi: 10.1515/cclm-2017-0792.

PMID:
29329103
9.

Neurofascin (NF)155- and NF186-Specific T Cell Response in a Patient Developing a Central Pontocerebellar Demyelination after 10 Years of CIDP.

Klehmet J, Staudt M, Diederich JM, Siebert E, Meinl E, Harms L, Meisel A.

Front Neurol. 2017 Dec 22;8:724. doi: 10.3389/fneur.2017.00724. eCollection 2017.

10.

Oral health-related quality of life depending on dental and periodontal health in different patients before and after liver transplantation.

Schmalz G, Meisel A, Kollmar O, Kauffels A, Slotta JE, Kottmann T, Haak R, Ziebolz D.

Clin Oral Investig. 2018 Jun;22(5):2039-2045. doi: 10.1007/s00784-017-2298-5. Epub 2017 Dec 14.

PMID:
29243116
11.

S1P receptor antagonists fingolimod and siponimod do not improve the outcome of experimental autoimmune myasthenia gravis mice after disease onset.

Pelz A, Schaffert H, Diallo R, Hiepe F, Meisel A, Kohler S.

Eur J Immunol. 2018 Mar;48(3):498-508. doi: 10.1002/eji.201747187. Epub 2017 Dec 19.

PMID:
29205338
12.

Selection bias in clinical stroke trials depending on ability to consent.

Hotter B, Ulm L, Hoffmann S, Katan M, Montaner J, Bustamante A, Meisel A.

BMC Neurol. 2017 Dec 4;17(1):206. doi: 10.1186/s12883-017-0989-9.

13.

Correction to: Incidence of severe sepsis and septic shock in German intensive care units: the prospective, multicentre INSEP study.

Marx G; SepNet Critical Care Trials Group.

Intensive Care Med. 2018 Jan;44(1):153-156. doi: 10.1007/s00134-017-4980-0.

PMID:
29196793
14.

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial.

van Schaik IN, Bril V, van Geloven N, Hartung HP, Lewis RA, Sobue G, Lawo JP, Praus M, Mielke O, Durn BL, Cornblath DR, Merkies ISJ; PATH study group.

Lancet Neurol. 2018 Jan;17(1):35-46. doi: 10.1016/S1474-4422(17)30378-2. Epub 2017 Nov 6. Erratum in: Lancet Neurol. 2018 Jan;17 (1):26. Lancet Neurol. 2018 Aug;17(8):661.

PMID:
29122523
15.

Neuronal Culture Microenvironments Determine Preferences in Bioenergetic Pathway Use.

Sünwoldt J, Bosche B, Meisel A, Mergenthaler P.

Front Mol Neurosci. 2017 Sep 29;10:305. doi: 10.3389/fnmol.2017.00305. eCollection 2017.

16.

Smoking cessation and outcome after ischemic stroke or TIA.

Epstein KA, Viscoli CM, Spence JD, Young LH, Inzucchi SE, Gorman M, Gerstenhaber B, Guarino PD, Dixit A, Furie KL, Kernan WN; IRIS Trial Investigators.

Neurology. 2017 Oct 17;89(16):1723-1729. doi: 10.1212/WNL.0000000000004524. Epub 2017 Sep 8.

PMID:
28887378
17.

Awakening with amantadine from a persistent vegetative state after subarachnoid haemorrhage.

Lehnerer SM, Scheibe F, Buchert R, Kliesch S, Meisel A.

BMJ Case Rep. 2017 Jul 24;2017. pii: bcr-2017-220305. doi: 10.1136/bcr-2017-220305.

18.

Precision medicine for hepatocelluar carcinoma using molecular pattern diagnostics: results from a preclinical pilot study.

Agarwal R, Cao Y, Hoffmeier K, Krezdorn N, Jost L, Meisel AR, Jüngling R, Dituri F, Mancarella S, Rotter B, Winter P, Giannelli G.

Cell Death Dis. 2017 Jun 8;8(6):e2867. doi: 10.1038/cddis.2017.229.

19.

Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 cases.

Schnitzler LJ, Schreckenbach T, Nadaj-Pakleza A, Stenzel W, Rushing EJ, Van Damme P, Ferbert A, Petri S, Hartmann C, Bornemann A, Meisel A, Petersen JA, Tousseyn T, Thal DR, Reimann J, De Jonghe P, Martin JJ, Van den Bergh PY, Schulz JB, Weis J, Claeys KG.

Orphanet J Rare Dis. 2017 May 11;12(1):86. doi: 10.1186/s13023-017-0640-2. Review.

20.

The Randomized Controlled STRAWINSKI Trial: Procalcitonin-Guided Antibiotic Therapy after Stroke.

Ulm L, Hoffmann S, Nabavi D, Hermans M, Mackert BM, Hamilton F, Schmehl I, Jungehuelsing GJ, Montaner J, Bustamante A, Katan M, Hartmann A, Ebmeyer S, Dinter C, Wiemer JC, Hertel S, Meisel C, Anker SD, Meisel A.

Front Neurol. 2017 Apr 24;8:153. doi: 10.3389/fneur.2017.00153. eCollection 2017.

Supplemental Content

Loading ...
Support Center